Dr. Wysock on Robotic Approaches in Cytoreductive Nephrectomy

James Wysock, MD
Published: Friday, Jan 26, 2018



James Wysock, MD, chief of the urology service at NYC Health and Hospitals at Bellevue, assistant professor, Department of Urology, NYU Langone’s Perlmutter Cancer Center, discusses the placement of novel robotic and minimally invasive approaches in nephrectomy.

Cytoreductive nephrectomy, a treatment to surgically remove renal cell carcinoma, is a way of removing the tumor and taking out most of the cancer with the understanding that some will remain. Though this is not generally a surgically sanctioned approach, it has been identified as a factor in improving patient outcomes when the disease has advanced or become metastatic.

Known to improve overall survival, surgeons are now employing novel robotic and minimally invasive approaches in nephrectomy to manage more and more advanced disease around the kidney, especially in more complex partial nephrectomies.

Even more options are available in the realm of cytoreductive nephrectomy and inferior vena cava thrombosis for very advanced disease because it offers lower morbidity for patients. Some of the poorer-risk patients who would ordinarily receive supportive care may also be candidates for receiving minimally invasive treatments.
 
SELECTED
LANGUAGE


James Wysock, MD, chief of the urology service at NYC Health and Hospitals at Bellevue, assistant professor, Department of Urology, NYU Langone’s Perlmutter Cancer Center, discusses the placement of novel robotic and minimally invasive approaches in nephrectomy.

Cytoreductive nephrectomy, a treatment to surgically remove renal cell carcinoma, is a way of removing the tumor and taking out most of the cancer with the understanding that some will remain. Though this is not generally a surgically sanctioned approach, it has been identified as a factor in improving patient outcomes when the disease has advanced or become metastatic.

Known to improve overall survival, surgeons are now employing novel robotic and minimally invasive approaches in nephrectomy to manage more and more advanced disease around the kidney, especially in more complex partial nephrectomies.

Even more options are available in the realm of cytoreductive nephrectomy and inferior vena cava thrombosis for very advanced disease because it offers lower morbidity for patients. Some of the poorer-risk patients who would ordinarily receive supportive care may also be candidates for receiving minimally invasive treatments.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
Community Practice Connections™: Current Status and the Future Potential of CAR T-Cell Therapy for Lymphoid Malignancies: The Experts Weigh-In on Recent Data and Clinical ExperienceJan 31, 20192.0
Publication Bottom Border
Border Publication
x